Yoshiki Ishii

Summary

Affiliation: Dokkyo University School of Medicine
Country: Japan

Publications

  1. ncbi Comparative analysis of circulating dendritic cell subsets in patients with atopic diseases and sarcoidosis
    Yumeko Hayashi
    Department of Pulmonary Medicine and Clinical Immunology, Dokkyo Medical University, Kitakobayashi 880, Mibu, Tochigi, 321 0293, Japan
    Respir Res 14:29. 2013
  2. ncbi Fractionated administration of carboplatin/paclitaxel reduces neurotoxicity in patients with advanced non-small cell lung cancer
    Yoshiki Ishii
    Department of Pulmonary Medicine and Clinical Immunology, Dokkyo Medical University School of Medicine, Mibu, Tochigi, Japan
    Anticancer Drugs 22:926-32. 2011
  3. ncbi Gefitinib prevents bleomycin-induced lung fibrosis in mice
    Yoshiki Ishii
    Department of Pulmonary Medicine and Clinical Immunology, Dokkyo Medical University School of Medicine, 800 Kitakobayashi, Mibu, Tochigi 321 0293, Japan
    Am J Respir Crit Care Med 174:550-6. 2006
  4. ncbi [A case of group G Streptococcus sepsis, chest wall abscess, and vertebral osteomyelitis mimicking a primary lung cancer with bone metastasis]
    Yumeko Hayashi
    Department of Pulmonary Medicine and Clinical Immunology, Dokkyo Medical University School of Medicine
    Nihon Kokyuki Gakkai Zasshi 45:76-80. 2007
  5. ncbi Relation between the antimicrobial susceptibility of clinical isolates of Pseudomonas aeruginosa from respiratory specimens and antimicrobial use density (AUD) from 2005 through 2008
    Yasutsugu Fukushima
    Department of Pulmonary Medicine and Clinical Immunology, Dokkyo University School of Medicine, Japan
    Intern Med 49:1333-40. 2010
  6. ncbi Leukotriene D4 stimulates collagen production from myofibroblasts transformed by TGF-beta
    Takuma Asakura
    Department of Pulmonary Medicine and Clinical Immunology, Dokkyo University School of Medicine, Japan
    J Allergy Clin Immunol 114:310-5. 2004
  7. ncbi A patient with bronchial asthma in whom eosinophilic bronchitis and bronchiolitis developed during treatment
    Yasutsugu Fukushima
    Department of Pulmonary Medicine and Clinical Immunology, Dokkyo University School of Medicine, Tochigi, Japan
    Allergol Int 59:87-91. 2010
  8. ncbi Effects of Th2 pulmonary inflammation in mice with bleomycin-induced pulmonary fibrosis
    Hirokuni Hirata
    Department of Pulmonary Medicine and Clinical Immunology, Dokkyo University School of Medicine, Tochigi, Japan
    Respirology 13:788-98. 2008
  9. ncbi Up-regulation of cysteinyl leukotriene 1 receptor by IL-13 enables human lung fibroblasts to respond to leukotriene C4 and produce eotaxin
    Kazuyuki Chibana
    Department of Pulmonary Medicine and Clinical Immunology, Dokkyo University School of Medicine, Tochigi, Japan
    J Immunol 170:4290-5. 2003
  10. ncbi A neutrophil elastase inhibitor prevents bleomycin-induced pulmonary fibrosis in mice
    Akihiro Takemasa
    Dokkyo Medical University School of Medicine, Tochigi, Japan
    Eur Respir J 40:1475-82. 2012

Collaborators

  • Kazuyuki Chibana
  • Hirokuni Hirata
  • Kuniyoshi Kamiya
  • Masafumi Arima
  • Gang Cheng
  • Y Hirakata
  • Takeshi Fukuda
  • Yumeko Hayashi
  • Yasutsugu Fukushima
  • Akihiro Takemasa
  • Sadatomo Tasaka
  • Masamitsu Tatewaki
  • Fumiya Fukushima
  • Ryo Arai
  • Issei Yamada
  • Kumiya Sugiyama
  • Makoto Sawafuji
  • Hidefumi Koh
  • Akitoshi Ishizaka
  • Takuma Asakura
  • Mitsumi Hata-Suzuki
  • Kazuki Mashio
  • Isano Hase
  • Aya Kamada
  • Hidenori Takizawa
  • Kazuki Obara
  • Wakako Yamada
  • Mitsutomo Kohno
  • Yuko Ogawa
  • Kazuhiro Yamaguchi
  • Koichi Kobayashi
  • Sarah E Richer
  • Naoki Hasegawa
  • Mie Shimizu
  • Claire M Doerschuk

Detail Information

Publications17

  1. ncbi Comparative analysis of circulating dendritic cell subsets in patients with atopic diseases and sarcoidosis
    Yumeko Hayashi
    Department of Pulmonary Medicine and Clinical Immunology, Dokkyo Medical University, Kitakobayashi 880, Mibu, Tochigi, 321 0293, Japan
    Respir Res 14:29. 2013
    ..We performed this study to compare circulating mDC, pDC, mDC1, and mDC2 subsets between Th1- and Th2-mediated diseases using CD1a and CD141, and to analyze the adequacy of CD1a and CD141 as a marker for mDC1s and mDC2s, respectively...
  2. ncbi Fractionated administration of carboplatin/paclitaxel reduces neurotoxicity in patients with advanced non-small cell lung cancer
    Yoshiki Ishii
    Department of Pulmonary Medicine and Clinical Immunology, Dokkyo Medical University School of Medicine, Mibu, Tochigi, Japan
    Anticancer Drugs 22:926-32. 2011
    ..Measurement of CPT by a neurometer is a useful tool to evaluate the neurotoxicity of anticancer drugs objectively...
  3. ncbi Gefitinib prevents bleomycin-induced lung fibrosis in mice
    Yoshiki Ishii
    Department of Pulmonary Medicine and Clinical Immunology, Dokkyo Medical University School of Medicine, 800 Kitakobayashi, Mibu, Tochigi 321 0293, Japan
    Am J Respir Crit Care Med 174:550-6. 2006
    ..However, there is a possibility that blocking the EGFR signal may inhibit epithelial cell repair, thereby exaggerating lung fibrosis...
  4. ncbi [A case of group G Streptococcus sepsis, chest wall abscess, and vertebral osteomyelitis mimicking a primary lung cancer with bone metastasis]
    Yumeko Hayashi
    Department of Pulmonary Medicine and Clinical Immunology, Dokkyo Medical University School of Medicine
    Nihon Kokyuki Gakkai Zasshi 45:76-80. 2007
    ..She was treated with intravenous penicillin for 4 weeks and oral amoxicillin for another 4 weeks. After 60 days of antibiotic treatment, the tumor vanished...
  5. ncbi Relation between the antimicrobial susceptibility of clinical isolates of Pseudomonas aeruginosa from respiratory specimens and antimicrobial use density (AUD) from 2005 through 2008
    Yasutsugu Fukushima
    Department of Pulmonary Medicine and Clinical Immunology, Dokkyo University School of Medicine, Japan
    Intern Med 49:1333-40. 2010
    ..aeruginosa clinical isolates during a 4-year period and annual trends in the overall usage of antimicrobials during the same period...
  6. ncbi Leukotriene D4 stimulates collagen production from myofibroblasts transformed by TGF-beta
    Takuma Asakura
    Department of Pulmonary Medicine and Clinical Immunology, Dokkyo University School of Medicine, Japan
    J Allergy Clin Immunol 114:310-5. 2004
    ..These data suggest that treatment with leukotriene receptor antagonists might prevent airway remodeling in patients with asthma...
  7. ncbi A patient with bronchial asthma in whom eosinophilic bronchitis and bronchiolitis developed during treatment
    Yasutsugu Fukushima
    Department of Pulmonary Medicine and Clinical Immunology, Dokkyo University School of Medicine, Tochigi, Japan
    Allergol Int 59:87-91. 2010
    ....
  8. ncbi Effects of Th2 pulmonary inflammation in mice with bleomycin-induced pulmonary fibrosis
    Hirokuni Hirata
    Department of Pulmonary Medicine and Clinical Immunology, Dokkyo University School of Medicine, Tochigi, Japan
    Respirology 13:788-98. 2008
    ..We studied the effects of Th2-type pulmonary inflammation on bleomycin-induced pulmonary fibrosis using Bcl6 transgenic mice...
  9. ncbi Up-regulation of cysteinyl leukotriene 1 receptor by IL-13 enables human lung fibroblasts to respond to leukotriene C4 and produce eotaxin
    Kazuyuki Chibana
    Department of Pulmonary Medicine and Clinical Immunology, Dokkyo University School of Medicine, Tochigi, Japan
    J Immunol 170:4290-5. 2003
    ..In the Th2 cytokine-rich milieu, such as that in bronchial asthma, CysLT1R expression on fibroblasts might be up-regulated, thereby allowing CysLTs to act effectively and increase eosinophilic inflammation...
  10. ncbi A neutrophil elastase inhibitor prevents bleomycin-induced pulmonary fibrosis in mice
    Akihiro Takemasa
    Dokkyo Medical University School of Medicine, Tochigi, Japan
    Eur Respir J 40:1475-82. 2012
    ..These results suggest that sivelestat alleviated bleomycin-induced pulmonary fibrosis via inhibition of both TGF-β activation and inflammatory cell recruitment in the lung...
  11. ncbi [Clinical utility of thoracoscopy under local anesthesia]
    Yoshiki Ishii
    Department of Pulmonary Medicine and Clinical Immunology, Dokkyo Medical University School of Medicine, Tochigi, Japan
    Kyobu Geka 60:692-8. 2007
    ..Scince medical thoracoscopy under local anesthesia is rapid, easy, safe, and well-tolerated procedure with an excellent diagnostic yield, it is recommended as a diagnostic procedure for cases with pleural diseases...
  12. ncbi Prevalence of airflow limitation in patients diagnosed and treated for symptoms of chronic bronchitis by general practitioners in Tochigi Prefecture, Japan
    Kazuyuki Chibana
    Department of Pulmonary Medicine and Clinical Immunology, Dokkyo University School of Medicine, Japan
    Intern Med 50:2277-83. 2011
    ....
  13. ncbi Anti-interleukin-9 antibody treatment inhibits airway inflammation and hyperreactivity in mouse asthma model
    Gang Cheng
    Department of Pulmonary Medicine, Dokkyo University School of Medicine, Mibu machi, Shimotsuga gun, Tochigi 321 0293, Japan
    Am J Respir Crit Care Med 166:409-16. 2002
    ..Taken together, our findings emphasize the importance of IL-9 in the pathogenesis of asthma and suggest that blockade of IL-9 may be a new therapeutic strategy for bronchial asthma...
  14. ncbi Trichosporon asahii-induced asthma in a family with Japanese summer-type hypersensitivity pneumonitis
    Yoichi Hirakata
    Department of Pulmonary Medicine, Jichi Medical School, Minamikawachi, Tochigi, Japan
    Ann Allergy Asthma Immunol 88:335-8. 2002
    ..Trichosporon species frequently induce summer-type hypersensitivity pneumonitis (SHP), which is the most prevalent type of hypersensitivity pneumonitis (HP) in Japan, but have not been reported to induce asthma...
  15. ncbi Role of Rho-kinase in reexpansion pulmonary edema in rabbits
    Makoto Sawafuji
    Dept of Surgery, Keio University, 35 Shinanomachi, Shinjuku ku, Tokyo 160 8582, Japan
    Am J Physiol Lung Cell Mol Physiol 289:L946-53. 2005
    ..These in vivo and in vitro observations suggest that the Rho/ROCK pathway contributes to the increase in alveolar barrier permeability associated with reexpansion pulmonary edema...
  16. ncbi Attenuation of endotoxin-induced acute lung injury by the Rho-associated kinase inhibitor, Y-27632
    Sadatomo Tasaka
    Department of Medicine, Keio University School of Medicine, 35 Shinanomachi, Tokyo 160-8582, Japan
    Am J Respir Cell Mol Biol 32:504-10. 2005
    ....
  17. ncbi [Tailor-made medicine for bronchial asthma]
    Kazuyuki Chibana
    Department of Pulmonary Medicine and Clinical Immunology, Dokkyo University School of Medicine
    Nippon Rinsho 60:189-96. 2002
    ..The information about polymorphisms, is accumulated, tailor-made medicine will be applicable to medical care of individual asthmatics...